Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Wegovy Batches Withdrawn Upon Discovery of Hair in a Pre-Filled Syringe - Featured image
Health

Wegovy Batches Withdrawn Upon Discovery of Hair in a Pre-Filled Syringe

Certain batches of Wegovy are being pulled from circulation because hair has been detected in pre-filled syringes. This action ensures patient safety and highlights the importance of quality control in pharmaceutical products. Consumers are advised to check for affected lots.

Shotlee·January 4, 2026·Updated Jan 27, 2026·1 min read
Share:

Information here is not meant to replace expert medical guidance, diagnosis, or therapy. Always avoid ignoring professional medical advice or postponing its pursuit based on what you've encountered here. Do not depend on these details as a substitute for consulting a healthcare provider. We do not suggest or support any particular examinations, items, processes, views, or other data that might be included. Refer to extra details.

Original source: www.theepochtimes.com

View original article →
#Wegovy#recall#hair contamination#syringe#drug safety
  1. Home
  2. Blog
  3. Wegovy Batches Withdrawn Upon Discovery of Hair in a Pre-Filled Syringe

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community